法律人 LawPlayer logo

資料由法律人 LawPlayer整理提供·UK legislation / curated by LawPlayer from legislation.gov.uk

Statutory Instrument

The National Health Service (Pharmaceutical Services) (Wales) (Miscellaneous Amendments) Regulations 2025

Citation
S.I. 2025/285 (W.)
As at
Sections
3
Section 1Title and coming into force

(1) The title of these Regulations is the National Health Service (Pharmaceutical Services) (Wales) (Miscellaneous Amendments) Regulations 2025.

(2) This regulation and regulation 3 come into force on 31 March 2025.

(3) Regulation 2 comes into force at 12:01 a.m. on 1 April 2025.

Section 2Amendments to the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020

(1) The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 are amended as follows.

(2) In regulation 2(1) (Interpretation)—

(a) in the definition of “Electronic prescription form”, in paragraph (b), for “ETP” substitute “electronic prescription” ,

(b) omit the definition of “ETP service”,

(c) in the appropriate place, insert—

“ Prescription only medicine ” (“ meddyginiaeth a roddir ar bresgripsiwn yn unig ”) means a medicine referred to in regulation 5(3) (classification of medicinal products) of the Human Medicines Regulations 2012;

(d) in the definition of “Repeatable prescription”, in paragraph (a)(ii), for “ETP” substitute “electronic prescription” .

(3) In Schedule 5—

(a) in Part 2, in the heading to paragraph 5A before “listed”, in each place it occurs, insert “ophthalmic” ,

(b) in Part 2, in paragraph 5A—

(i) for “a listed”, in each place it occurs, substitute “an ophthalmic listed” ;

(ii) in sub paragraph (3)(a), for “paragraph” substitute “sub-paragraph” ; and

(iii) in sub-paragraph (5), for “paragraph” substitute “sub-paragraph” ;

(c) in Part 2, in paragraph 9 , in sub-paragraph (8C)(b), omit “directly”;

(d) in Part 2, for paragraph 20(4) substitute—

(4) The NHS pharmacist must, in appropriate cases, keep and maintain a record of any advice given and any interventions or referrals made (in particular of clinically significant interventions) under this paragraph.

(e) in Part 3, in paragraph 23(6B) , for “paragraph” substitute “sub-paragraph” .

Section 3Amendments to the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024

(1) The National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024 are amended as follows.

(2) In regulation 2(2), for “2” substitute “2(1)” .

(3) In regulation 3—

(a) in paragraph (2), for “a listed”, in each place it occurs, substitute “an ophthalmic listed” , and

(b) in paragraph (14)(a), for “(6)(c)” substitute “(6A)” .

(4) In the Schedule—

(a) in paragraph 2, in the definition of “qualifying optometrist” for “Ophthalmic Combined List” substitute “combined list” , and

(b) in paragraph 3, in the inserted regulation 4A(1) for “will” substitute “must” .

3 sections

Cite this legislation

The National Health Service (Pharmaceutical Services) (Wales) (Miscellaneous Amendments) Regulations 2025 (legislation.gov.uk, OGL v3.0). Retrieved via LawPlayer, https://lawplayer.com/uk/act/wsi-2025-285 (accessed 2026-07-07)

Contains public sector information licensed under the Open Government Licence v3.0.

OGL-3

本頁資料來源:legislation.gov.uk (The National Archives)·整理提供:法律人 LawPlayer· lawplayer.com